Literature DB >> 26152151

Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity.

Rita Morigi, Alessandra Locatelli, Alberto Leoni, Mirella Rambaldi1.   

Abstract

Cancer is a disease of remarkable importance in the world today and is projected to become the primary cause of death within the coming years, therefore the design and development of new antitumor agents is one of the most pressing research areas in medicinal chemistry. Considering the importance of thiazole ring as scaffold present in a wide range of therapeutic agents, the medicinal chemists have been encouraged to synthesize a large number of novel antitumors bearing this heterocycle, which furnish extensive synthetic possibilities due to the presence of several reaction sites. The present review describes the patents from 2008 to present concerning new thiazole compounds useful for the development of new drug molecules. It has been divided according to the molecular target and describes the pathways involved in the biological activities and the structure of the most potent compounds, together with the screening results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26152151     DOI: 10.2174/1574892810666150708110432

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  8 in total

Review 1.  YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.

Authors:  Brandon J Burkhart; Christopher J Schwalen; Greg Mann; James H Naismith; Douglas A Mitchell
Journal:  Chem Rev       Date:  2017-03-03       Impact factor: 60.622

2.  Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.

Authors:  Mehlika Dilek Altıntop; Belgin Sever; Gülşen Akalın Çiftçi; Ahmet Özdemir
Journal:  Molecules       Date:  2018-05-31       Impact factor: 4.411

3.  Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.

Authors:  Mehlika Dilek Altıntop; Halil Ibrahim Ciftci; Mohamed O Radwan; Belgin Sever; Zafer Asım Kaplancıklı; Taha F S Ali; Ryoko Koga; Mikako Fujita; Masami Otsuka; Ahmet Özdemir
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

4.  One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.

Authors:  Abdelwahed R Sayed; Sobhi M Gomha; Eman A Taher; Zeinab A Muhammad; Hesham R El-Seedi; Hatem M Gaber; Mahgoub M Ahmed
Journal:  Drug Des Devel Ther       Date:  2020-04-03       Impact factor: 4.162

5.  In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.

Authors:  Belgin Sever; Mehlika Dilek Altıntop; Ahmet Özdemir; Gülşen Akalın Çiftçi; Doha E Ellakwa; Hiroshi Tateishi; Mohamed O Radwan; Mahmoud A A Ibrahim; Masami Otsuka; Mikako Fujita; Halil I Ciftci; Taha F S Ali
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

6.  Synthesis, Molecular Docking Study, and Cytotoxic Activity against MCF Cells of New Thiazole-Thiophene Scaffolds.

Authors:  Sobhi M Gomha; Sayed M Riyadh; Bader Huwaimel; Mohie E M Zayed; Magda H Abdellattif
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

7.  Evaluation of the Binding Relationship of the RdRp Enzyme to Novel Thiazole/Acid Hydrazone Hybrids Obtainable through Green Synthetic Procedure.

Authors:  Jehan Y Al-Humaidi; Mohamed G Badrey; Ashraf A Aly; AbdElAziz A Nayl; Mohie E M Zayed; Ohoud A Jefri; Sobhi M Gomha
Journal:  Polymers (Basel)       Date:  2022-08-03       Impact factor: 4.967

Review 8.  Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.

Authors:  Dimitris Matiadis; Marina Sagnou
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.